BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38203299)

  • 21. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
    Noack J; Choi J; Richter K; Kopp-Schneider A; Régnier-Vigouroux A
    Cell Death Dis; 2014 Sep; 5(9):e1425. PubMed ID: 25255218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Sphingolipid Rheostat in Gliomas.
    Zaibaq F; Dowdy T; Larion M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
    Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion.
    Sousa N; Geiß C; Bindila L; Lieberwirth I; Kim E; Régnier-Vigouroux A
    BMC Cancer; 2023 Aug; 23(1):762. PubMed ID: 37587449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
    Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
    Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingolipids in macroautophagy.
    Lavieu G; Scarlatti F; Sala G; Carpentier S; Levade T; Ghidoni R; Botti J; Codogno P
    Methods Mol Biol; 2008; 445():159-73. PubMed ID: 18425450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C16‑ceramide and sphingosine 1‑phosphate/S1PR2 have opposite effects on cell growth through mTOR signaling pathway regulation.
    Kim MH; Park JW; Lee EJ; Kim S; Shin SH; Ahn JH; Jung Y; Park I; Park WJ
    Oncol Rep; 2018 Nov; 40(5):2977-2987. PubMed ID: 30226616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceramide in the molecular mechanisms of neuronal cell death. The role of sphingosine-1-phosphate.
    Czubowicz K; Strosznajder R
    Mol Neurobiol; 2014 Aug; 50(1):26-37. PubMed ID: 24420784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.
    Matula K; Collie-Duguid E; Murray G; Parikh K; Grabsch H; Tan P; Lalwani S; Garau R; Ong Y; Bain G; Smith AD; Urquhart G; Bielawski J; Finnegan M; Petty R
    BMC Cancer; 2015 Oct; 15():762. PubMed ID: 26493335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse Sphingolipid Profiles in Rectal and Colon Cancer.
    Markowski AR; Błachnio-Zabielska AU; Pogodzińska K; Markowska AJ; Zabielski P
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.
    Baran Y; Salas A; Senkal CE; Gunduz U; Bielawski J; Obeid LM; Ogretmen B
    J Biol Chem; 2007 Apr; 282(15):10922-34. PubMed ID: 17303574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases.
    Hait NC; Oskeritzian CA; Paugh SW; Milstien S; Spiegel S
    Biochim Biophys Acta; 2006 Dec; 1758(12):2016-26. PubMed ID: 16996023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse Liver Compensates Loss of Sgpl1 by Secretion of Sphingolipids into Blood and Bile.
    Spohner AK; Jakobi K; Trautmann S; Thomas D; Schumacher F; Kleuser B; Lütjohann D; El-Hindi K; Grösch S; Pfeilschifter J; Saba JD; Meyer Zu Heringdorf D
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
    Momchilova A; Pankov R; Staneva G; Pankov S; Krastev P; Vassileva E; Hazarosova R; Krastev N; Robev B; Nikolova B; Pinkas A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.